Abstract
Antipsychotics are drugs commonly prescribed to treat a variety of psychiatric conditions. They are classified as typical and atypical, depending on their affinity for dopaminergic and serotonergic receptors. Although neurons have been assumed to be the major mediators of the antipsychotic pharmacological effects, glia, particularly astrocytes, have emerged as important cellular targets for these drugs. In the present study, we investigated the effects of acute treatments with the antipsychotics risperidone and haloperidol of hippocampal slices and astrocyte cultures, focusing on neuron-glia communication and how antipsychotics act in astrocytes. For this, we obtained hippocampal slices and primary astrocyte cultures from 30-day-old Wistar rats and incubated them with risperidone or haloperidol (1 and 10 μM) for 30 min and 24 h, respectively. We evaluated metabolic and enzymatic activities, the glutathione level, the release of inflammatory and trophic factors, as well as the gene expression of signaling proteins. Haloperidol increased glucose metabolism; however, neither of the tested antipsychotics altered the glutathione content or glutamine synthetase and Na+K+-ATPase activities. Haloperidol induced a pro-inflammatory response and risperidone promoted an anti-inflammatory response, while both antipsychotics seemed to decrease trophic support. Haloperidol and risperidone increased Nrf2 and HO-1 gene expression, but only haloperidol upregulated NFκB and AMPK gene expression. Finally, astrocyte cultures confirmed the predominant effect of the tested antipsychotics on glia and their opposite effects on astrocytes. Therefore, antipsychotics cause functional alterations in the hippocampus. This information is important to drive future research for strategies to attenuate antipsychotics-induced neural dysfunction, focusing on glia.






Similar content being viewed by others
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Li P, Snyder GL, Vanover KE (2016) Dopamine targeting drugs for the treatment of schizophrenia: past, present and future. Curr Top Med Chem 16:3385–3403. https://doi.org/10.2174/1568026616666160608084834
Mauri MC, Paletta S, Maffini M et al (2014) Clinical pharmacology of atypical antipsychotics: an update. EXCLI J 13:1163–1191
Schmitz I, da Silva A, Bobermin LD et al (2023) The Janus face of antipsychotics in glial cells: focus on glioprotection. Exp Biol Med Maywood NJ 248:2120–2130. https://doi.org/10.1177/15353702231222027
Stockmeier CA, DiCarlo JJ, Zhang Y et al (1993) Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. J Pharmacol Exp Ther 266:1374–1384
Ali T, Sisay M, Tariku M et al (2021) Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies. PLoS ONE 16:e0257129. https://doi.org/10.1371/journal.pone.0257129
Divac N, Prostran M, Jakovcevski I, Cerovac N (2014) Second-generation antipsychotics and extrapyramidal adverse effects. BioMed Res Int 2014:656370. https://doi.org/10.1155/2014/656370
Siafis S, Wu H, Wang D et al (2023) Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis. Mol Psychiatry 28:3267–3277. https://doi.org/10.1038/s41380-023-02203-y
Sykes DA, Moore H, Stott L et al (2017) Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. Nat Commun 8:763. https://doi.org/10.1038/s41467-017-00716-z
Bobermin LD, da Silva A, Souza DO, Quincozes-Santos A (2018) Differential effects of typical and atypical antipsychotics on astroglial cells in vitro. Int J Dev Neurosci Off J Int Soc Dev Neurosci 69:1–9. https://doi.org/10.1016/j.ijdevneu.2018.06.001
Dietz AG, Goldman SA, Nedergaard M (2020) Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry 7:272–281. https://doi.org/10.1016/S2215-0366(19)30302-5
Quincozes-Santos A, Bobermin LD, Kleinkauf-Rocha J et al (2009) Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells. Prog Neuropsychopharmacol Biol Psychiatry 33:11–15. https://doi.org/10.1016/j.pnpbp.2008.08.023
Quincozes-Santos A, Santos CL, de Souza Almeida RR et al (2021) Gliotoxicity and glioprotection: the dual role of glial cells. Mol Neurobiol 58:6577–6592. https://doi.org/10.1007/s12035-021-02574-9
Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98:239–389. https://doi.org/10.1152/physrev.00042.2016
Bal A, Bachelot T, Savasta M et al (1994) Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Brain Res Mol Brain Res 23:204–212. https://doi.org/10.1016/0169-328x(94)90227-5
Zanassi P, Paolillo M, Montecucco A et al (1999) Pharmacological and molecular evidence for dopamine D(1) receptor expression by striatal astrocytes in culture. J Neurosci Res 58:544–552. https://doi.org/10.1002/(sici)1097-4547(19991115)58:4%3c544::aid-jnr7%3e3.0.co;2-9
Quincozes-Santos A, Bobermin LD, Tonial RPL et al (2010) Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions. Eur Arch Psychiatry Clin Neurosci 260:475–481. https://doi.org/10.1007/s00406-009-0095-0
MacDowell KS, García-Bueno B, Madrigal JLM et al (2013) Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation. Int J Neuropsychopharmacol 16:121–135. https://doi.org/10.1017/S1461145711001775
Sugino H, Futamura T, Mitsumoto Y et al (2009) Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 33:303–307. https://doi.org/10.1016/j.pnpbp.2008.12.006
Wegrzyn D, Juckel G, Faissner A (2022) Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models. Int J Mol Sci 23:5482. https://doi.org/10.3390/ijms23105482
Jørgensen KN, Nesvåg R, Gunleiksrud S et al (2016) First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia. Eur Arch Psychiatry Clin Neurosci 266:451–460. https://doi.org/10.1007/s00406-015-0650-9
Nardin P, Tortorelli L, Quincozes-Santos A et al (2009) S100B secretion in acute brain slices: modulation by extracellular levels of Ca2+ and K+. Neurochem Res 34:1603–1611. https://doi.org/10.1007/s11064-009-9949-0
Zanotto C, Abib RT, Batassini C et al (2013) Non-specific inhibitors of aquaporin-4 stimulate S100B secretion in acute hippocampal slices of rats. Brain Res 1491:14–22. https://doi.org/10.1016/j.brainres.2012.10.065
Bellaver B, Souza DG, Souza DO, Quincozes-Santos A (2017) Hippocampal astrocyte cultures from adult and aged rats reproduce changes in glial functionality observed in the aging brain. Mol Neurobiol 54:2969–2985. https://doi.org/10.1007/s12035-016-9880-8
Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol Clifton NJ 108:347–352. https://doi.org/10.1385/0-89603-472-0:347
dos Santos AQ, Nardin P, Funchal C et al (2006) Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch Biochem Biophys 453:161–167. https://doi.org/10.1016/j.abb.2006.06.025
Wyse AT, Streck EL, Barros SV et al (2000) Methylmalonate administration decreases Na+, K+-ATPase activity in cerebral cortex of rats. NeuroReport 11:2331–2334. https://doi.org/10.1097/00001756-200007140-00052
Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+ -stimulated ATPase activity. Anal Biochem 157:375–380. https://doi.org/10.1016/0003-2697(86)90640-8
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
de Souza DF, Wartchow K, Hansen F et al (2013) Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone. Prog Neuropsychopharmacol Biol Psychiatry 43:14–22. https://doi.org/10.1016/j.pnpbp.2012.12.001
Nardin P, Tramontina AC, Quincozes-Santos A et al (2011) In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 35:1291–1296. https://doi.org/10.1016/j.pnpbp.2011.04.004
Gawlik-Kotelnicka O, Mielicki W, Rabe-Jabłońska J et al (2016) Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture. Acta Neuropsychiatr 28:38–44. https://doi.org/10.1017/neu.2015.47
Lee H-G, Wheeler MA, Quintana FJ (2022) Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov 21:339–358. https://doi.org/10.1038/s41573-022-00390-x
Verkhratsky A, Butt A, Li B et al (2023) Astrocytes in human central nervous system diseases: a frontier for new therapies. Signal Transduct Target Ther 8:396. https://doi.org/10.1038/s41392-023-01628-9
Mühlbauer V, Möhler R, Dichter MN et al (2021) Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013304.pub2
Raut S, Bhalerao A, Powers M et al (2023) Hypometabolism, Alzheimer’s disease, and possible therapeutic targets: an overview. Cells 12:2019. https://doi.org/10.3390/cells12162019
Kowalchuk C, Castellani LN, Chintoh A et al (2019) Antipsychotics and glucose metabolism: how brain and body collide. Am J Physiol-Endocrinol Metab 316:E1–E15. https://doi.org/10.1152/ajpendo.00164.2018
Pizzolato G, Soncrant TT, Rapoport SI (1984) Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics. J Neurochem 43:724–732. https://doi.org/10.1111/j.1471-4159.1984.tb12792.x
Carli M, Kolachalam S, Longoni B et al (2021) Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences. Pharmaceuticals 14:238. https://doi.org/10.3390/ph14030238
Murashita M, Inoue T, Kusumi I et al (2007) Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia. Psychiatry Clin Neurosci 61:54–58. https://doi.org/10.1111/j.1440-1819.2007.01610.x
Quincozes-Santos A, Gottfried C (2011) Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann N Y Acad Sci 1215:72–78. https://doi.org/10.1111/j.1749-6632.2010.05857.x
Pillai A, Parikh V, Terry AV, Mahadik SP (2007) Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 41:372–386. https://doi.org/10.1016/j.jpsychires.2006.01.011
Wyse AT, Siebert C, Bobermin LD et al (2020) Changes in inflammatory response, redox status and Na+, K+-ATPase activity in primary astrocyte cultures from female wistar rats subject to ovariectomy. Neurotox Res 37:445–454. https://doi.org/10.1007/s12640-019-00128-5
Al-Amin MM, Nasir Uddin MM, Mahmud Reza H (2013) Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol 11:144–151. https://doi.org/10.9758/cpn.2013.11.3.144
McNamara RK, Jandacek R, Rider T, Tso P (2011) Chronic risperidone normalizes elevated pro-inflammatory cytokine and C-reactive protein production in omega-3 fatty acid deficient rats. Eur J Pharmacol 652:152–156. https://doi.org/10.1016/j.ejphar.2010.11.010
da Cruz Jung IE, Machado AK, da Cruz IBM et al (2016) Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels. Psychopharmacology 233:1715–1723. https://doi.org/10.1007/s00213-015-4079-7
Garcia JM, Stillings SA, Leclerc JL et al (2017) Role of Interleukin-10 in Acute Brain Injuries. Front Neurol 8:244. https://doi.org/10.3389/fneur.2017.00244
Bahrambeigi S, Khatamnezhad M, Asri-Rezaei S et al (2021) Pro-oxidant and degenerative effects of haloperidol under inflammatory conditions in rat; the involvement of SIRT1 and NF-κB signaling pathways. Vet Res Forum Int. https://doi.org/10.30466/vrf.2019.105811.2514
Bobermin LD, Roppa RHA, Quincozes-Santos A (2019) Adenosine receptors as a new target for resveratrol-mediated glioprotection. Biochim Biophys Acta Mol Basis Dis 1865:634–647. https://doi.org/10.1016/j.bbadis.2019.01.004
Lopes CR, Cunha RA, Agostinho P (2021) Astrocytes and adenosine A2A receptors: active players in Alzheimer’s disease. Front Neurosci 15:666710. https://doi.org/10.3389/fnins.2021.666710
Capuzzi E, Bartoli F, Crocamo C et al (2017) Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: a meta-analysis. Neurosci Biobehav Rev 77:122–128. https://doi.org/10.1016/j.neubiorev.2017.03.003
Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297–306. https://doi.org/10.1002/da.22084
Tourjman V, Kouassi É, Koué M-È et al (2013) Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res 151:43–47. https://doi.org/10.1016/j.schres.2013.10.011
Silva AC, Lemos C, Gonçalves FQ et al (2018) Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer’s disease. Neurobiol Dis 117:72–81. https://doi.org/10.1016/j.nbd.2018.05.024
Cintrón-Colón AF, Almeida-Alves G, Boynton AM, Spitsbergen JM (2020) GDNF synthesis, signaling, and retrograde transport in motor neurons. Cell Tissue Res 382:47–56. https://doi.org/10.1007/s00441-020-03287-6
Luo G, Huang Y, Jia B et al (2018) Quetiapine prevents Aβ25-35-induced cell death in cultured neuron by enhancing brain-derived neurotrophic factor release from astrocyte. NeuroReport 29:92–98. https://doi.org/10.1097/WNR.0000000000000911
Dalwadi DA, Kim S, Schetz JA (2017) Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia. Neurochem Int 105:21–31. https://doi.org/10.1016/j.neuint.2017.02.003
Shao Z, Dyck LE, Wang H, Li X-M (2006) Antipsychotic drugs cause glial cell line–derived neurotrophic factor secretion from C6 glioma cells. J Psychiatry Neurosci 31:32–37
Mitra S, Werner C, Dietz DM (2022) Neuroadaptations and TGF-β signaling: emerging role in models of neuropsychiatric disorders. Mol Psychiatry 27:296–306. https://doi.org/10.1038/s41380-021-01186-y
Dresselhaus EC, Meffert MK (2019) Cellular specificity of NF-κB function in the nervous system. Front Immunol 10:1043. https://doi.org/10.3389/fimmu.2019.01043
Karin M, Delhase M (2000) The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin Immunol 12:85–98. https://doi.org/10.1006/smim.2000.0210
Caruso G, Grasso M, Fidilio A et al (2020) Antioxidant properties of second-generation antipsychotics: focus on microglia. Pharm Basel Switz 13:457. https://doi.org/10.3390/ph13120457
Liddell JR (2017) Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration? Antioxidants. https://doi.org/10.3390/antiox6030065
Markiewicz I, Lukomska B (2006) The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol Exp 66(4):343–358
Gomes C, Ferreira R, George J et al (2013) Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia. J Neuroinflammation 10:16. https://doi.org/10.1186/1742-2094-10-16
Acknowledgements
This study was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Universidade Federal do Rio Grande do Sul, and Instituto Nacional de Ciência e Tecnologia (INCTEN/CNPq).
Funding
This research was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção.
Author information
Authors and Affiliations
Contributions
AS and AQS conceptualized the study. AS, LDB, CLS, RRSA, LJL, TMS, and MPS performed the experiments. AS, LDB, and AQS performed statistical analysis and written the original draft of the manuscript. MCL, ATSW, CAG, and AQS provided resources and materials/chemicals. All authors revised, edited, and approved the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Ethical Approval
This study protocol was reviewed and approved by the Federal University of Rio Grande do Sul Animal Care and Use Committee (process number 35557).
Consent to Participate
Not applicable.
Consent to Publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
da Silva, A., Bobermin, L.D., Santos, C.L. et al. Glia-related Acute Effects of Risperidone and Haloperidol in Hippocampal Slices and Astrocyte Cultures from Adult Wistar Rats: A Focus on Inflammatory and Trophic Factor Release. Neurochem Res 50, 22 (2025). https://doi.org/10.1007/s11064-024-04273-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11064-024-04273-y